Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
International Journal of Clinical Pharmacy|August 11, 2011
The clinical pharmacist's contributions within the multidisciplinary patient care team of an intern nephrology wardGunar Stemer, Rosa Lemmens-GruberBMC Nephrology|July 23, 2011
Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature reviewGunar Stemer, Rosa Lemmens-GruberBMC Clinical Pharmacology|September 8, 2009
Evaluation of risk factor management of patients treated on an internal nephrology ward: a pilot studyGunar Stemer, Sonja Zehetmayer, Rosa Lemmens-GruberEuropean Journal of Hospital Pharmacy : Science and Practice|August 29, 2024
Costs, challenges and opportunities of decentralised chimeric antigen receptor T-cell production: a literature review and clinical experts' interviewsGunar Stemer, Tarquin Mittermayr, Petra Schnell-Inderst, et al.European Journal of Hospital Pharmacy : Science and Practice|February 1, 2024
Liquid antimicrobials: a national analysis of critical shortagesNikolaus Riesenhuber, Maxine Krauss, Korinna Moßburger, et al.Pharmacy (Basel, Switzerland)|June 29, 2018
Pharmacy Practice and Education in AustriaThierry Langer, Helmut Spreitzer, Teresa Ditfurth, et al.Children (Basel, Switzerland)|April 23, 2022
The Impact of Clinical Pharmacy Services in a Tertiary Care Center Specialized in Pediatric Hemato-OncologyChristina Gradwohl, Gernot Engstler, Martina Anditsch, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 17, 2017
Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and AustriaGeorge Dranitsaris, Lesley G Shane, Jean-Philippe Galanaud, et al.Archives of Orthopaedic and Trauma Surgery|July 3, 2026
Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational studyLukas Böck, Katharina Kerschan-Schindl, Martin Frossard, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 18, 2021
Tackling the challenges of nanomedicines: are we ready?John B Hertig, Vinod P Shah, Beat Flühmann, et al.Pageof 2